Pharmacy chains activity analysis

Pharmacy chains activity analysis

Russian pharmaceuticals retail chain segment evaluation, both on the level of the state and in particular regions. Pharmacy chains development forecast


Product sales and separate market development forecast, based on unique mathematical models

Business and marketing plan development

Development of detailed business-plans, required to evaluate the reasonability of project start

Search of partners for contract production in Russia

Potential partners search and evaluation, based on their technical opportunities, appropriate experience, and reputation

Monitoring of import substitution

assessment of the main trends of import substitution policies and localization processes in the pharmaceutical market in Russia, the key beneficiaries and companies at risk

Import of Veterinary Drugs and Feed Supplements to Russia (March and Q1 2022)

Friday, May 6, 2022

In January–March 2022, Russia imported 9.6 billion rubles’ worth of veterinary drugs (customs clearance and VAT included), down 2.6% from the same period in 2021. However, the growth rate in 2021 was 6.8%. As for feed supplements, the import volume was 12.7 billion rubles, up 37% from Q1 2021. The last time the growth rates were double-digit was back in 2020 (11.5%).

In physical terms, the growth rate of the import of veterinary drugs was –11%, with 6.85 million packages imported. The import volume of feed supplements was 2.1 million packages, or 37,000 tons. The growth rates were 12% in packages and 10.5% in tons.

Interestingly, the crisis that unfolded after the start of a special military operation in Ukraine has so far not had a significant impact on the import of both veterinary drugs and feed supplements. In March 2022, the growth rate of the veterinary drug import was 10.2% against 16.8% in February. As for feed supplements, the growth rate in March 2022 was 43% in monetary terms, but January and February also saw double-digit growth rates of more than 30%. In physical terms, however, the import still suffered a significant decrease of –12.3% in tons, an obvious consequence of the logistical difficulties that arose in the early stages of the crisis.

Geographically, veterinary drug imports in March more or less remained the same, except that the import from Poland increased noticeably, which seems rather strange, since imports through Poland became much more complicated after the start of the crisis. However, imports of feed supplements underwent more serious changes, in particular, the imports from China and Turkey went up from March 2021 (3.2 and 3 times, respectively). Surprisingly, the imports from UK increased, and quite sharply, too (13 times from March 2021).

Spanish Biokorm Intemational had the highest growth rates in March 2022 among the top 20 manufacturers of veterinary drugs. The company’s imports grew 75 times from March 2021, with Amoxivet and Amoxigran, antibiotic (amoxicillin) drugs for livestock, contributing to the growth rate the most. The Spanish company is followed by Zhejiang Dayang Biotech Group (China). The company increased its imports 10 times from March 2021, mainly thanks to Enduro, an antibiotic for livestock. As for the largest importers of feed supplements, German Phytobiotics increased its imports 13 times, with Sangrovit, an additive to increase the productivity of poultry, contributing to the growth rates. Chinese Tongliao Meihua Biological Sci-Tech also showed significant growth (4.5 times from March 2021), mainly due to the import of Fodder Additive Valine.

Growth rates of the import of veterinary drugs and feed supplements to Russia (EEU countries excluded), free circulation prices including customs clearance and VAT (2017–2021, Q1 2022)